Nova Mentis Life Science Corp.
Psychedelic-derived therapeutic compounds and formulations for mental health and neurological disorders
Updated · restartlife.co
- Sector
- Biotech
- Headquarters
- VANCOUVER, A1
- Latest Form D
- $12K, Aug 2020
- Total capital
- $188K
- Grants
- —
- No SBIR or STTR on record
- Sector median 1 award
- Raised
- $188K
- 3 Form D · Aug 2020
- 74 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 1
- 0 granted · 1 pending
- Below sector median 2 patents
Capital Timeline
Federal ↑Equity ↓201620172018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $12,170 | |
| Private capital raised | Form D · SEC | $88,297 | |
| Private capital raised | Form D · SEC | $87,543 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1168 | Neumentum, Inc. | — | $27M |
| 1169 | Tioga Pharmaceuticals Inc | — | $24M |
| 1170 | KODIAK BP, LLC | — | $13M |
| 1171 | Nova Mentis Life Science Corp. | — | $188K |
| 1172 | SCYNEXIS, INC. | — | $5.5M |
| 1173 | MediSix Therapeutics, Inc. | — | $35M |
| 1174 | ISOThrive Inc. | — | $17M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Keith AndersonDirector
- Steven FeldmanDirector
- Doug MacdonellDirector
- Dr. Aylia MohammadiDirector
- Kelly PladsonExecutive Officer
- William RascanDirector · Executive Officer
- Jamie RobinsonExecutive Officer
Patents
- DIAGNOSING, MONITORING AND TREATING NEUROLOGICAL DISEASE WITH PSYCHOACTIVE TRYPTAMINE DERIVATIVES AND mRNA MEASUREMENTSapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.